Biotech

All Articles

' Medical instinct' led FDA consultants to back Zevra's rare health condition med

.Zevra Rehabs' rare illness drug appears to become on the path to confirmation this fall after acqui...

Pfizer takes $230M hit after axing stopped working DMD gene treatment

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) gene therapy failure has blown a $230 thousand ...

AC Immune observes 'spots' prospective in Alzheimer's medicine information

.After greater than 20 years of work with neurodegenerative conditions, Swiss biotech air conditioni...

GSK drops ph. 2 HPV vaccine over shortage of best-in-class prospective

.GSK has actually scrapped a period 2 individual papillomavirus (HPV) vaccine from its pipeline afte...

OS Therapies refiles $6M IPO to finance HER2 medication, preclinical ADCs

.OS Therapies will list on the NYSE American sell substitution today through a $6.4 thousand IPO tha...

ALX's waning CD47 reaction fee delivers inventory spiraling down

.ALX Oncology's stage 2 stomach cancer action rate has compromised. After finding its CD47 blocker q...

Ionis axes eye condition coming from targets of Roche-partnered possibility after records dissatisfy

.Yet Another of Ionis Pharmaceuticals' key midphase readouts has actually disappointed desires, prom...

Biogen's chief executive officer stated no dangerous sell 2023. He's ready to become vibrant

.While Biogen's pharma peers are actually seeking for late-stage properties along with little risk, ...

Instil refills pipe in $2B biobucks deal with ImmunOnco

.Instil Bio has been a biotech looking for a pipeline after it ditched its lead properties over the ...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually restored civil liberties to an early Alzheimer's health condition plan to Denal...